Drug Type Monoclonal antibody |
Synonyms HY 0102, HY-0102, HY000102 |
Target |
Action antagonists |
Mechanism NKG2A antagonists(killer cell lectin like receptor C1 antagonists) |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Pancreatic Cancer | Phase 2 | - | 30 Nov 2024 | |
Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1 | China | 12 Dec 2024 | |
Advanced Malignant Solid Neoplasm | Phase 1 | China | 31 Oct 2023 | |
Colorectal Cancer | Phase 1 | China | 31 Oct 2023 | |
Hepatocellular Carcinoma | Phase 1 | China | 31 Oct 2023 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | United States | 03 May 2022 |